US4749791AExpiredUtility

Benzo[f]quinoline intermediates

69
Assignee: HOFFMANN LA ROCHEPriority: Jan 23, 1986Filed: Nov 18, 1987Granted: Jun 7, 1988
Est. expiryJan 23, 2006(expired)· nominal 20-yr term from priority
A61P 25/28C07D 225/06C07D 221/10C07D 225/02C07D 227/08
69
PatentIndex Score
10
Cited by
3
References
4
Claims

Abstract

Benzazecinediones of the formula <IMAGE> I wherein R1 and R2 are independently hydrogen or chlorine, R3 is hydrogen, fluorine, chlorine, bromine or methoxy, R4 is hydrogen, chlorine or methoxy and R5 is hydrogen, acetyl, propionyl, benzoyl, chlorobenzoyl, methoxybenzoyl or phenylacetyl, with the proviso that 2 or 3 of the groups R1 to R4 are hydrogen, as well as many of the corresponding benzo[f]quinolines from which these benzazecinediones can be prepared by oxidation are suitable for the control or prevention of cerebral insufficiency or for the improvement of cognitive functions in mammals. They can be produced according to various processes and can be prepared into pharmaceutical compositions.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A compound of the formula ##STR8## wherein R 1  and R 2  are independently hydrogen or chlorine, R 3  is hydrogen, fluorine, chlorine, bromine, or methoxy, R 4  is hydrogen, chlorine or methoxy, and R 5  is hydrogen, acetyl, propionyl, benzoyl, chlorobenzoyl, methoxybenzoyl or phenylacetyl, with the proviso that 2 or 3 of the groups R 1  to R 4  are hydrogen. 
     
     
       2. 4-Acetyl-8-chloro-1,2,3,4,5,6-hexahydrobenzo[f]quinoline. 
     
     
       3. 4-Acetyl-10-chloro-1,2,3,4,5,6-hexahydrobenzo[f]quinoline. 
     
     
       4. 8-Chloro-4-(p-chlorobenzoyl)-1,2,3,4,5,6-hexahydrobenzo[f]quinoline.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.